Evidence map›Paper›PMID 39245688›Full record

ArticleEJNMMI reports2024

[

Xiao Li, Mingming Yu, Jian Yang, Danni Li, Rou Li, Juanli Mao, Changjing Zuo, Zeying Liang, Qiang Li, Chao Cheng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Challenges and Opportunities in Radioligand Therapy.Journal of nuclear medicine technology · 2025
    Review
  3. Comparative Evaluation of (World journal of nuclear medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xiao Li *Department of Nuclear Medicine, Shanghai Changhai Hospital, Shanghai, 204333, China. lixiao_nm@smmu.edu.cn.ORCID http://orcid.org/0000-0003-4135-2275
Mingming Yu *Department of Radiology, The Affiliated People's Hospital of Ningbo University, Ningbo, 315040, Zhejiang, China.
Jian Yang *School of Medicine, Shanghai University, Shanghai, 200444, China.
Danni LiDepartment of Nuclear Medicine, Shanghai Changhai Hospital, Shanghai, 204333, China.
Rou LiDepartment of Nuclear Medicine, Shanghai Changhai Hospital, Shanghai, 204333, China.
Juanli MaoDepartment of Nuclear Medicine, Shanghai Changhai Hospital, Shanghai, 204333, China.
Changjing ZuoDepartment of Nuclear Medicine, Shanghai Changhai Hospital, Shanghai, 204333, China.
Zeying LiangSchool of Medicine, Shanghai University, Shanghai, 200444, China.
Qiang LiDepartment of Radiology, The Affiliated People's Hospital of Ningbo University, Ningbo, 315040, Zhejiang, China. rmliqiang@nbu.edu.cn.
Chao ChengDepartment of Nuclear Medicine, Shanghai Changhai Hospital, Shanghai, 204333, China. 13501925757@163.com.

Funding

Shanghai Hospital Development Center SHDC1202310the First Affiliated Hospital of Naval Medical University (Shanghai Changhai Hospital) "Guhai Plan in the 14th Five-Year Plan period" GH145-22 and GH145XKQ-03
6 · The paper itself

Abstract

purposeTo evaluate the physiological distribution and tumour detection ability of [

methodsAs a retrospective study, clinical and PET data of PCa patients who underwent dual-phase [

results[

conclusion[

Indexed as

[18F]AlF-PSMA-11[68Ga]Ga-PSMA-11Dual-phase scansProstate CancerPSMA PET

Identifiers

PMID39245688
PMCPMC11381491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.